Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat Combined With Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Endometrial Hyperplasia
NCT07714070Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of orlistat in endometrial cancer (EC), Atypical endometrial hyperplasia (AEH), sponsored by Peking University People's Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
orlistat
03
Conditions
endometrial cancer (EC)Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT07714070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07714070.